HC Wainwright & Co. initiated coverage on Reviva Pharmaceuticals with a new price target

1/24/22 6:07:15 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Reviva Pharmaceuticals with a rating of Buy and set a new price target of $10.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RVPH

Date	Price Target	Rating	Analyst
9/20/2023	$12.00	Buy	ROTH MKM
6/8/2023	$17.00	Speculative Buy	The Benchmark Company
1/24/2022	$10.00	Buy	HC Wainwright & Co.
7/26/2021	$10.00	Buy	Maxim Group